19-7740410-G-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_021155.4(CD209):​c.*2629C>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.537 in 619,714 control chromosomes in the GnomAD database, including 91,533 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.53 ( 21507 hom., cov: 32)
Exomes 𝑓: 0.54 ( 70026 hom. )

Consequence

CD209
NM_021155.4 3_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.365

Publications

16 publications found
Variant links:
Genes affected
CD209 (HGNC:1641): (CD209 molecule) This gene encodes a C-type lectin that functions in cell adhesion and pathogen recognition. This receptor recognizes a wide range of evolutionarily divergent pathogens with a large impact on public health, including leprosy and tuberculosis mycobacteria, the Ebola, hepatitis C, HIV-1 and Dengue viruses, and the SARS-CoV acute respiratory syndrome coronavirus. The protein is organized into four distinct domains: a C-terminal carbohydrate recognition domain, a flexible tandem-repeat neck domain, a transmembrane region and an N-terminal cytoplasmic domain involved in internalization. This gene is closely related in terms of both sequence and function to a neighboring gene, CLEC4M (Gene ID: 10332), also known as L-SIGN. The two genes differ in viral recognition and expression patterns, with this gene showing high expression on the surface of dendritic cells. Polymorphisms in the neck region are associated with protection from HIV-1 infection, while single nucleotide polymorphisms in the promoter of this gene are associated with differing resistance and susceptibility to and severity of infectious disease, including rs4804803, which is associated with SARS severity. [provided by RefSeq, May 2020]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.598 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_021155.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CD209
NM_021155.4
MANE Select
c.*2629C>A
3_prime_UTR
Exon 7 of 7NP_066978.1
CD209
NR_026692.2
n.3967C>A
non_coding_transcript_exon
Exon 6 of 6
CD209
NM_001144897.2
c.*2629C>A
3_prime_UTR
Exon 7 of 7NP_001138369.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CD209
ENST00000315599.12
TSL:1 MANE Select
c.*2629C>A
3_prime_UTR
Exon 7 of 7ENSP00000315477.6
ENSG00000288669
ENST00000678003.1
n.*290+1157C>A
intron
N/AENSP00000504497.1
ENSG00000288669
ENST00000676543.1
n.70+5108C>A
intron
N/AENSP00000503143.1

Frequencies

GnomAD3 genomes
AF:
0.528
AC:
80247
AN:
151844
Hom.:
21480
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.471
Gnomad AMI
AF:
0.479
Gnomad AMR
AF:
0.607
Gnomad ASJ
AF:
0.584
Gnomad EAS
AF:
0.258
Gnomad SAS
AF:
0.519
Gnomad FIN
AF:
0.568
Gnomad MID
AF:
0.560
Gnomad NFE
AF:
0.558
Gnomad OTH
AF:
0.550
GnomAD4 exome
AF:
0.540
AC:
252691
AN:
467752
Hom.:
70026
Cov.:
4
AF XY:
0.540
AC XY:
136538
AN XY:
252646
show subpopulations
African (AFR)
AF:
0.460
AC:
5469
AN:
11892
American (AMR)
AF:
0.629
AC:
11375
AN:
18090
Ashkenazi Jewish (ASJ)
AF:
0.586
AC:
8542
AN:
14566
East Asian (EAS)
AF:
0.263
AC:
7486
AN:
28498
South Asian (SAS)
AF:
0.536
AC:
27721
AN:
51690
European-Finnish (FIN)
AF:
0.577
AC:
25272
AN:
43806
Middle Eastern (MID)
AF:
0.553
AC:
1184
AN:
2140
European-Non Finnish (NFE)
AF:
0.559
AC:
151954
AN:
271988
Other (OTH)
AF:
0.546
AC:
13688
AN:
25082
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
5300
10600
15901
21201
26501
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
676
1352
2028
2704
3380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.529
AC:
80324
AN:
151962
Hom.:
21507
Cov.:
32
AF XY:
0.527
AC XY:
39115
AN XY:
74246
show subpopulations
African (AFR)
AF:
0.471
AC:
19496
AN:
41406
American (AMR)
AF:
0.608
AC:
9288
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.584
AC:
2026
AN:
3470
East Asian (EAS)
AF:
0.259
AC:
1338
AN:
5174
South Asian (SAS)
AF:
0.519
AC:
2501
AN:
4818
European-Finnish (FIN)
AF:
0.568
AC:
5984
AN:
10542
Middle Eastern (MID)
AF:
0.565
AC:
166
AN:
294
European-Non Finnish (NFE)
AF:
0.558
AC:
37926
AN:
67960
Other (OTH)
AF:
0.551
AC:
1162
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1976
3953
5929
7906
9882
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
710
1420
2130
2840
3550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.541
Hom.:
41942
Bravo
AF:
0.529
Asia WGS
AF:
0.437
AC:
1518
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
2.3
DANN
Benign
0.76
PhyloP100
0.36
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11465421; hg19: chr19-7805296; COSMIC: COSV52659436; COSMIC: COSV52659436; API